Company / Operating Income
Imunon, Inc. Operating Income History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$24.9M
FY2023
5-year range
-$24.9M / -$18.5M
FY2019-FY2023
Trend
-18.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$18M to -$25M over the past 2 years.
Based on SEC 10-K filings.
-$25M in FY2023.
Declined from -$18M to -$25M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating income decreased 18.6% year-over-year.
- Peak operating income was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$24.9M | -18.6% |
| FY2022 | -$21.0M | -13.6% |
| FY2021 | -$18.5M | +10.1% |
| FY2020 | -$20.6M | +2.4% |
| FY2019 | -$21.1M | -14.1% |
| FY2018 | -$18.5M | -19.8% |
| FY2015 | -$15.4M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026